We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Debenhams Raised After Strong Report

Fri, 17th Apr 2015 08:58

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
---------
FTSE 100
----------
CANACCORD RAISES SMITHS GROUP PRICE TARGET TO 1410 (1390) PENCE - 'HOLD'
----------
EXANE BNP RAISES SMITHS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
NOMURA RAISES SMITHS GROUP PRICE TARGET TO 1400 (1320) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SMITHS GROUP PRICE TARGET TO 1520 (1310) PENCE - 'OVERWEIGHT'
----------
EXANE BNP RAISES WEIR GROUP PRICE TARGET TO 1925 (1500) PENCE
----------
EXANE BNP RAISES WEIR GROUP TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP CUTS GKN TO 'NEUTRAL' ('OUTPERFORM') - TARGET 380 PENCE
----------
CREDIT SUISSE RAISES WHITBREAD PRICE TARGET TO 6200 (5300) PENCE - 'OUTPERFORM'
----------
CANACCORD RAISES KINGFISHER PRICE TARGET TO 334 (300) PENCE - 'HOLD'
----------
CANACCORD RAISES DIAGEO PRICE TARGET TO 1515 (1465) PENCE - 'SELL'
----------
JPMORGAN RAISES UNILEVER PLC PRICE TARGET TO 2900 (2750) PENCE - 'UNDERWEIGHT'
----------
Liberum Raises Unilever Price Target To 2,400p From 2,310p, Reiterates Sell
----------
JPMORGAN RAISES SABMILLER PRICE TARGET TO 4000 (3650) PENCE - 'OVERWEIGHT'
----------
UBS RAISES SABMILLER PRICE TARGET TO 3600 (3500) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES SABMILLER PRICE TARGET TO 3920 (3700) PENCE - 'BUY'
----------
Berenberg Raises SABMiller Price Target To 3,920p From 3,700p, Reiterates Buy
----------
DAVY INITIATES ROYAL MAIL WITH 'UNDERPERFORM' - TARGET 380 PENCE
----------
GOLDMAN RAISES MEGGITT PRICE TARGET TO 592 (573) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BAE SYSTEMS PRICE TARGET TO 611 (577) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4850 (4800) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES SHIRE PRICE TARGET TO 5900 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
EXANE BNP RAISES MELROSE INDUSTRIES TARGET TO 315 (300) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS PETRA DIAMONDS PRICE TARGET TO 220 (230) PENCE - 'BUY'
----------
EXANE BNP CUTS VESUVIUS PRICE TARGET TO 515 (540) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SPIRAX-SARCO PRICE TARGET TO 3550 (3500) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS ROTORK PRICE TARGET TO 2600 (2610) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ROTORK TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
EXANE BNP RAISES IMI PRICE TARGET TO 1150 (1100) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES HALMA PRICE TARGET TO 800 (780) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SPECTRIS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2375 (1850) PENCE
----------
BARCLAYS RAISES SPECTRIS PRICE TARGET TO 2535 (2065) PENCE - 'OVERWEIGHT'
----------
CREDIT SUISSE RAISES JUPITER FUND PRICE TARGET TO 430 (378) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES PLAYTECH PRICE TARGET TO 1030 (960) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS CARILLION PRICE TARGET TO 305 (330) PENCE - 'NEUTRAL'
----------
PANMURE RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3000 (2700) PENCE - 'HOLD'
----------
SOCGEN RAISES DEBENHAMS PRICE TARGET TO 80 (67) PENCE - 'HOLD'
----------
UBS RAISES DEBENHAMS PRICE TARGET TO 90 (85) PENCE - 'BUY'
----------
CITIGROUP RAISES DEBENHAMS TO 'BUY' ('NEUTRAL') - TARGET 95 (75) PENCE
----------
BARCLAYS RAISES MORGAN ADVANCED MATERIALS TARGET TO 350 (305) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS RAISES LAIRD PRICE TARGET TO 370 (315) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES IMI PRICE TARGET TO 1380 (1340) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HALMA PRICE TARGET TO 715 (650) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS DOMINO PRINTING TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
BARCLAYS RAISES DOMINO PRINTING PRICE TARGET TO 915 (730) PENCE
----------
BARCLAYS RAISES RENISHAW PRICE TARGET TO 2825 (2425) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES QINETIQ PRICE TARGET TO 208 (204) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES QINETIQ TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 220 (210) PENCE
----------
BARCLAYS INITIATES MONEYSUPERMARKET WITH 'OVERWEIGHT' - TARGET 315 PENCE
----------
TRADERS: HSBC RAISES PENNON GROUP PRICE TARGET TO 970 (960) PENCE
----------
GOLDMAN CUTS ULTRA ELECTRONICS PRICE TARGET TO 1833 (2011) PENCE - 'NEUTRAL'
----------
GOLDMAN RESUMES COBHAM WITH 'NEUTRAL' - TARGET 329 PENCE
----------
GOLDMAN CUTS PETROFAC TO 'BUY' ('CONVICTION BUY LIST') - TARGET 1130 PENCE
----------
GOLDMAN RAISES HUNTING TO 'CONVICTION BUY' ('BUY') - TARGET 709 (622) PENCE
----------
MAIN MARKET AND AIM
----------
CANACCORD RAISES ONESAVINGS BANK TO 'BUY' ('HOLD') - TARGET 316 (290) PENCE
----------
JPMORGAN CUTS MOTHERCARE PRICE TARGET TO 235 (239) PENCE - 'OVERWEIGHT'
----------
JPMORGAN INITIATES URBAN & CIVIC WITH 'NEUTRAL' - TARGET 300 PENCE
----------
Cantor Fitzgerald Raises Chariot Oil & Gas Price Target To 20p From 12p, Reiterates Buy
----------
BARCLAYS RAISES OXFORD INSTRUMENTS PRICE TARGET TO 1000 (860) PENCE
----------
BARCLAYS RAISES OXFORD INSTRUMENTS TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.